Stay updated on Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial
Sign up to get notified when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.

Latest updates to the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange Detected- Added: Revision: v3.2.0 update badge. - Removed: Ovarian cancer resource under Genetic and Rare Diseases Information Center topics, and removal of Revision: v3.0.2.SummaryDifference0.3%
- Check21 days agoChange DetectedAdded v3.1.0; removed the Ovarian cancer resource and the v3.0.2 revision.SummaryDifference0.3%
- Check36 days agoChange DetectedThe version label was updated from v3.0.1 to v3.0.2, and the Back to Top element was removed.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check50 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of various scientific terms related to antibodies and proteins. Notably, the previous version's references to specific cancer types and certain drug classifications have been removed.SummaryDifference2%
- Check64 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.